Cervical cancer is a malignant tumor that develops in the area where the cervix meets the cervical canal, a narrow area adjacent to the vagina. The disease can be asymptomatic for a long time, and its early signs, such as bleeding and discomfort, often go unnoticed. The main cause of this pathology is a persistent infection caused by oncogenic types of the human papillomavirus. Timely consultation with a gynecologist ensures a high chance of a full recovery.
Modern medicine allows not only to successfully treat this disease in its early stages but also to effectively prevent it through screening and vaccination. Comprehensive diagnostics and personalized cancer treatment, including surgical, radiation, and drug treatments, are provided at the K+31 Clinic in Moscow using cutting-edge equipment and internationally recognized specialists.
A classification system that takes into account the histological structure of the tumor and its extent in the body is used to determine patient management and prognosis.
Based on cellular structure, there are two main types of malignant cervical lesions:
The stage of the pathology is determined according to the international FIGO classification based on the results of physical, instrumental, and morphological examinations. It reflects the anatomical distribution of the neoplasia.
Determining the FIGO staging system is necessary for choosing the optimal treatment plan, which may include both organ-preserving interventions in the early stages and radical surgery combined with combination therapy for advanced forms of the disease.
Today, programs aimed at detecting the disease in apparently healthy women before any symptoms appear are actively used. Their fundamental goal is to detect precancerous changes and early, clinically asymptomatic forms of cancer, when treatment is most effective and the prognosis is favorable.
Two methods are used:
The optimal strategy is to combine Pap and HPV testing, which significantly increases screening sensitivity and allows for the determination of further patient monitoring strategies.
If suspicious symptoms are present or the initial screening results are positive, the diagnosis moves into a more in-depth phase. The specialist performs a visual and manual assessment of the reproductive tract:
If abnormalities are detected, the doctor prescribes a more extensive instrumental examination. A colposcopy is performed. This is a detailed examination of the cervix under significant optical magnification. The mucosa is treated with acetic acid and Lugol's solution. Healthy and abnormal tissues react to the reagents differently: atypical areas do not stain, but remain light. This indicates the need for a targeted biopsy with histological examination to verify the diagnosis.
Removing a small tissue sample from the most suspicious area allows the doctor to examine not only individual cells but also the tissue structure as a whole. Histological analysis provides a definitive answer regarding the presence or absence of invasive cancer, its type, and degree of differentiation.
The underlying cause of this pathology is HPV infection. Strains classified as highly oncogenic produce the oncoproteins E6 and E7. These proteins inactivate cellular defense mechanisms by suppressing the functions of the tumor suppressors p53 and pRb, ultimately leading to genomic instability, uncontrolled proliferation, and malignancy of epithelial cells. Although types 16 and 18 bear the primary pathogenic burden, other strains, such as 31, 33, and 45, are also responsible for some cases.
HPV infection is an important, but not the only, condition for the development of this pathology. Even the presence of the virus in combination with additional risk factors does not automatically lead to cancer. The vast majority of cases of infection are resolved by the body's own immune system. But even if the virus is detected, it's important not to panic and instead focus on regular monitoring by a specialist and lifestyle changes. This approach can significantly reduce potential risks.
The extent of surgical intervention directly depends on the extent of the cancer. Modern gynecological oncology strives to perform organ-preserving surgeries in the early stages. The following may be performed:
Radiotherapy is a highly effective method that can be used either alone, for example, when surgery is contraindicated, or in combination with surgery and chemotherapy.
Two main forms of radiation are used:
The most effective treatment for locally advanced cancer is chemoradiation therapy—concurrent radiation and chemotherapy. This significantly increases tumor radiosensitivity and improves long-term outcomes.
The use of cytotoxic pharmacological agents solves several problems depending on the clinical situation:
A comprehensive rehabilitation program begins immediately after completion of the main course of therapy. It is aimed at minimizing its consequences and returning you to a full life.
This award is given to clinics with the highest ratings according to user ratings, a large number of requests from this site, and in the absence of critical violations.
This award is given to clinics with the highest ratings according to user ratings. It means that the place is known, loved, and definitely worth visiting.
The ProDoctors portal collected 500 thousand reviews, compiled a rating of doctors based on them and awarded the best. We are proud that our doctors are among those awarded.
Экстренная помощь
General information about the pathology
Cervical cancer, also known as cervical cancer, develops from abnormal changes in the cells of the cervical mucosa. Anatomically, this area connects the lower part of the uterus to the vagina. One of the characteristics of this area is the so-called transformation zone, or the area where glandular epithelial cells meet the stratified squamous epithelial cells of the vaginal portion of the cervix. It is in this zone that, in the vast majority of cases, the pathological process begins—the uncontrolled division of atypical cells, forming a neoplasm.
The vast majority of cases—over 95%—are directly linked to the persistence, or long-term survival, of highly oncogenic types of human papillomavirus (HPV), primarily types 16 and 18. HPV is a fairly common sexually transmitted infection, but the immune system often clears it on its own. However, with prolonged viral presence, its DNA can integrate into the cell genome, causing uncontrolled cell division and malignant transformation. This process is slow. On average, 10-15 years pass from infection and the appearance of early changes (dysplasia or cervical intraepithelial neoplasia) to the development of cancer.
According to the WHO, cervical cancer is the fourth most common cancer in women. This statistic underscores the social significance of the problem. Crucially, the disease can be prevented and managed, ensuring a favorable prognosis. The long precancerous period provides a unique window of opportunity for effective diagnosis and intervention.
The current strategy for combating cervical cancer is based on two key areas: primary prevention through HPV vaccination and secondary prevention through regular screening.